GT Biopharma (GTBP)
GT Biopharma on one page: short interest, daily short volume, fails to deliver, large holders, earnings dates and insider trades. Listed on Nasdaq.
279K
Short interest
settlement 2026-10-15
7.2
Days to cover
+2.8 days vs prior
43.2%
Short share of volume
2026-11-02
620
Fails to deliver
settlement 2026-10-14
Fri 13 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in GTBP is 278,799 shares, up 22,185 shares over the last month. Over the last 48 readings it ranged from 11,069 shares (29 November 2024) to 4,784,652 shares (15 July 2026). The latest reading sits at the bottom of that range. At the reported average volume of 39K shares a day that is 7.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/gtbp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 278,799 | +7.5% | 38,611 | 7.22 |
| 2026-09-30 | 259,425 | +1.1% | 58,776 | 4.41 |
| 2026-09-15 | 256,614 | -93.3% | 187,344 | 1.37 |
| 2026-08-31 | 3,842,169 | -5.4% | 384,595 | 9.99 |
| 2026-08-14 | 4,063,295 | +3.7% | 438,727 | 9.26 |
| 2026-07-31 | 3,918,534 | -18.1% | 505,305 | 7.75 |
| 2026-07-15 | 4,784,652 | +39.7% | 1,147,913 | 4.17 |
| 2026-06-30 | 3,424,425 | +35.6% | 1,413,329 | 2.42 |
| 2026-06-15 | 2,525,134 | +26.5% | 1,543,953 | 1.64 |
| 2026-05-29 | 1,996,213 | -3.8% | 2,006,709 | 1.00 |
| 2026-05-15 | 2,075,177 | +243.3% | 2,320,983 | 1.00 |
| 2026-04-30 | 604,557 | -9.9% | 688,008 | 1.00 |
| 2026-04-15 | 671,073 | -10.2% | 530,178 | 1.27 |
| 2026-03-31 | 747,375 | -26.7% | 654,579 | 1.14 |
| 2026-03-13 | 1,019,371 | -51.2% | 729,020 | 1.40 |
| 2026-02-27 | 2,089,377 | -20.5% | 923,696 | 2.26 |
| 2026-02-13 | 2,629,402 | -2.3% | 1,881,600 | 1.40 |
| 2026-01-30 | 2,691,277 | +11.0% | 798,754 | 3.37 |
| 2026-01-15 | 2,425,158 | +14.9% | 2,049,905 | 1.18 |
| 2025-12-31 | 2,111,313 | +45.3% | 2,660,073 | 1.00 |
| 2025-12-15 | 1,453,242 | -11.2% | 1,084,191 | 1.34 |
| 2025-11-28 | 1,636,186 | +14.6% | 818,134 | 2.00 |
| 2025-11-14 | 1,427,430 | +8.9% | 1,739,498 | 1.00 |
| 2025-10-31 | 1,310,410 | +25.4% | 581,898 | 2.25 |
| 2025-10-15 | 1,044,888 | +327.8% | 7,583,718 | 1.00 |
| 2025-09-30 | 244,248 | -18.4% | 539,761 | 1.00 |
| 2025-09-15 | 299,507 | +63.6% | 714,421 | 1.00 |
| 2025-08-29 | 183,043 | -29.9% | 147,981 | 1.24 |
| 2025-08-15 | 260,999 | -7.5% | 75,152 | 3.47 |
| 2025-07-31 | 282,275 | +3.2% | 79,147 | 3.57 |
| 2025-07-15 | 273,519 | -11.4% | 140,458 | 1.95 |
| 2025-06-30 | 308,730 | +40.3% | 83,081 | 3.72 |
| 2025-06-13 | 220,120 | +45.0% | 68,291 | 3.22 |
| 2025-05-30 | 151,779 | +315.6% | 156,013 | 1.00 |
| 2025-05-15 | 36,519 | -5.5% | 6,293 | 5.80 |
| 2025-04-30 | 38,658 | -23.7% | 29,074 | 1.33 |
| 2025-04-15 | 50,641 | -30.0% | 16,981 | 2.98 |
| 2025-03-31 | 72,301 | -23.2% | 28,773 | 2.51 |
| 2025-03-14 | 94,195 | -62.4% | 49,501 | 1.90 |
| 2025-02-28 | 250,247 | +35.8% | 3,019,222 | 1.00 |
| 2025-02-14 | 184,328 | -6.2% | 22,935 | 8.04 |
| 2025-01-31 | 196,523 | +5.1% | 46,621 | 4.22 |
| 2025-01-15 | 186,909 | +107.7% | 484,507 | 1.00 |
| 2024-12-31 | 89,991 | +556.0% | 2,014,282 | 1.00 |
| 2024-12-13 | 13,718 | +23.9% | 29,871 | 1.00 |
| 2024-11-29 | 11,069 | -43.0% | 18,323 | 1.00 |
| 2024-11-15 | 19,411 | +9.5% | 23,708 | 1.00 |
| 2024-10-31 | 17,725 | +70.8% | 31,388 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of GTBP volume is 43.2%, down 2.0 points over the last five sessions. Over the last 30 readings it ranged from 36.0% (1 October 2026) to 74.8% (25 September 2026). The latest reading is 12.0 points below the 30-session average of 55.2%, on 14K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 6K | 14K | 43.2% | 10 |
| 2026-10-30 | 6K | 13K | 50.3% | 0 |
| 2026-10-29 | 18K | 30K | 58.9% | 0 |
| 2026-10-28 | 9K | 21K | 43.6% | 183 |
| 2026-10-27 | 26K | 50K | 52.1% | 0 |
| 2026-10-26 | 44K | 97K | 45.1% | 0 |
| 2026-10-23 | 19K | 33K | 57.2% | 15 |
| 2026-10-22 | 21K | 41K | 51.0% | 2,803 |
| 2026-10-21 | 61K | 93K | 65.9% | 11,086 |
| 2026-10-20 | 17K | 28K | 61.3% | 0 |
| 2026-10-19 | 9K | 19K | 49.3% | 0 |
| 2026-10-16 | 17K | 31K | 53.8% | 30 |
| 2026-10-15 | 17K | 30K | 55.3% | 8 |
| 2026-10-14 | 11K | 19K | 58.3% | 0 |
| 2026-10-13 | 5K | 12K | 40.8% | 0 |
| 2026-10-12 | 11K | 25K | 43.3% | 100 |
| 2026-10-09 | 9K | 24K | 38.3% | 0 |
| 2026-10-08 | 10K | 17K | 58.0% | 0 |
| 2026-10-07 | 5K | 8K | 66.4% | 0 |
| 2026-10-06 | 9K | 13K | 69.7% | 0 |
| 2026-10-05 | 14K | 24K | 60.0% | 0 |
| 2026-10-02 | 19K | 30K | 61.9% | 14 |
| 2026-10-01 | 7K | 19K | 36.0% | 0 |
| 2026-09-30 | 7K | 16K | 43.3% | 0 |
| 2026-09-29 | 10K | 15K | 64.0% | 6 |
| 2026-09-28 | 17K | 23K | 71.4% | 0 |
| 2026-09-25 | 32K | 43K | 74.8% | 0 |
| 2026-09-24 | 10K | 14K | 70.0% | 0 |
| 2026-09-23 | 16K | 25K | 62.0% | 1,241 |
| 2026-09-22 | 23K | 46K | 50.7% | 648 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 14 October 2026, the fails-to-deliver balance in GTBP is 620 shares, down 8,345 shares over the last settlement date. Over the last 30 readings it ranged from 2 shares (25 September 2026) to 42,579 shares (14 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-14 | 620 | $6.50 | $4K |
| 2026-10-13 | 8,965 | $6.80 | $61K |
| 2026-10-09 | 7,118 | $5.96 | $42K |
| 2026-10-08 | 4,183 | $6.20 | $26K |
| 2026-10-07 | 5,074 | $6.37 | $32K |
| 2026-10-06 | 6,639 | $6.16 | $41K |
| 2026-10-05 | 4,166 | $6.10 | $25K |
| 2026-10-02 | 422 | $6.20 | $3K |
| 2026-10-01 | 6,034 | $6.47 | $39K |
| 2026-09-30 | 1,738 | $6.88 | $12K |
| 2026-09-29 | 121 | $6.80 | $823 |
| 2026-09-28 | 8,232 | $6.89 | $57K |
| 2026-09-25 | 2 | $6.83 | $14 |
| 2026-09-24 | 242 | $7.10 | $2K |
| 2026-09-23 | 575 | $7.18 | $4K |
| 2026-09-22 | 5,086 | $7.18 | $37K |
| 2026-09-21 | 88 | $7.16 | $630 |
| 2026-09-18 | 2,242 | $7.49 | $17K |
| 2026-09-17 | 981 | $7.81 | $8K |
| 2026-09-16 | 11,685 | $9.00 | $105K |
| 2026-09-15 | 37,896 | $11.63 | $441K |
| 2026-09-14 | 42,579 | $8.61 | $367K |
| 2026-09-11 | 18,981 | $6.18 | $117K |
| 2026-09-10 | 3,994 | $5.98 | $24K |
| 2026-09-09 | 4,313 | $5.25 | $23K |
| 2026-09-08 | 100 | $0.24 | $24 |
| 2026-09-04 | 16,022 | $0.25 | $4K |
| 2026-09-03 | 10,523 | $0.28 | $3K |
| 2026-09-02 | 1,559 | $0.29 | $452 |
| 2026-09-01 | 2,838 | $0.29 | $823 |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for GTBP in the last 90 days. The most recent filings are listed below. Latest filing: Ohri Manu (CFO & Secretary) on 2023-08-11.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2023-08-11 | Ohri Manu | CFO & Secretary | Other transaction | 200K | $0.29 | $57K | 0 |
| 2023-08-11 | Ohri Manu | CFO & Secretary | Grant | 200K | $0.29 | $58K | 200K |
| 2023-08-11 | Ohri Manu | CFO & Secretary | Other transaction | 200K | $0.29 | $58K | 300K |
| 2023-08-11 | Breen Michael Martin | Executive Chairman/Interim CEO | Grant | 200K | $0.29 | $58K | 856K |
| 2023-04-11 | Breen Michael Martin | Executive Chairman/Interim CEO | Buy | 50K | $0.50 | $25K | 656K |
| 2023-04-06 | Ohri Manu | CFO & Secretary | Buy | 50K | $0.50 | $25K | 50K |
| 2022-07-15 | Ohri Manu | CFO & Secretary | Other transaction | 100K | $0.00 | $0 | 100K |
| 2022-07-15 | Ohri Manu | CFO & Secretary | Other transaction | 100K | $0.00 | $0 | 0 |
| 2022-07-15 | Ohri Manu | CFO & Secretary | Grant | 100K | $0.00 | $0 | 100K |
| 2022-07-15 | Breen Michael Martin | Exec. Chair. and Interim CEO | Grant | 278K | $0.00 | $0 | 606K |
| 2021-02-25 | Breen Michael Martin | Director | Conversion | 40K | $3.40 | $137K | 318K |
| 2021-02-25 | Breen Michael Martin | Director | Conversion | 10K | $3.40 | $34K | 328K |
| 2021-02-16 | Berk Gregory | Director | Grant | 278K | $0.00 | $0 | 278K |
| 2021-02-16 | Wendel Bruce | Director | Grant | 348K | $0.00 | $0 | 353K |
| 2021-02-16 | Breen Michael Martin | Director | Grant | 278K | $0.00 | $0 | 278K |
| 2020-12-22 | Wendel Bruce | Director | Buy | 1K | $8.87 | $12K | 5K |
| 2020-12-22 | Wendel Bruce | Director | Buy | 441 | $8.73 | $4K | 5K |
| 2020-12-22 | Weldon Steven W | Other | Sell | 48K | $0.40 | $19K | 3.7M |
| 2020-12-21 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.30 | $15K | 3.9M |
| 2020-12-21 | Weldon Steven W | Other | Sell | 36K | $0.34 | $12K | 3.8M |
| 2020-12-21 | Weldon Steven W | Other | Sell | 50K | $0.33 | $17K | 3.8M |
| 2020-12-18 | Weldon Steven W | Other | Sell | 50K | $0.30 | $15K | 3.9M |
| 2020-12-17 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.31 | $16K | 4.0M |
| 2020-12-17 | Weldon Steven W | Other | Sell | 50K | $0.30 | $15K | 4.0M |
| 2020-12-16 | Weldon Steven W | Other | Sell | 50K | $0.30 | $15K | 4.1M |
| 2020-12-15 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.30 | $15K | 4.2M |
| 2020-12-15 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.30 | $15K | 4.2M |
| 2020-12-15 | Weldon Steven W | Other | Sell | 50K | $0.32 | $16K | 4.1M |
| 2020-12-14 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.28 | $14K | 4.3M |
| 2020-12-14 | Weldon Steven W | Other | Sell | 46K | $0.29 | $13K | 4.3M |
| 2020-12-14 | Weldon Steven W | Other | Sell | 50K | $0.29 | $15K | 4.3M |
| 2020-12-11 | Weldon Steven W | Former Officer and Director | Sell | 50K | $0.25 | $13K | 4.5M |
| 2020-12-11 | Weldon Steven W | Other | Sell | 50K | $0.26 | $13K | 4.4M |
| 2020-11-16 | Wendel Bruce | Director | Buy | 3K | $3.14 | $10K | 3K |
| 2020-06-02 | Cataldo Tony | CEO | Sell | 4.2M | $0.00 | $0 | 6.5M |
| 2020-05-13 | Weldon Steven W | CFO | Sell | 2.3M | $0.00 | $0 | 4.5M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of GTBP in its latest filing, on Schedule 13G (passive). The holder is RainForest Partners, LLC at 10.0% of the class (180,258 shares), filed 2026-09-15 for an event on 2026-09-15.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-09-15 | 13G | RainForest Partners, LLCcorporation | 180K | 10.0% | 2026-09-15 |
What this page is
GT Biopharma in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows GT Biopharma (GTBP), SEC CIK 109657, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-09-15.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2025-11-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2023-08-11.JSON and CSV
- Company record
- EDGAR filing index for CIK 109657Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of GTBP is sold short?
What is GTBP's daily short volume?
Does GTBP have fails to deliver?
Are GTBP insiders buying or selling?
Who owns 5% or more of GTBP?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.